JCB logo
Get More Out of Microscopy - Agilent iMIC 2000
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 31 January 2005. doi:10.1083/jcb.200404112
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 168, Number 3, 501-511
This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, Y.
Right arrow Articles by Chapman, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, Y.
Right arrow Articles by Chapman, H. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Article

 Regulation of {alpha}5ß1 integrin conformation and function by urokinase receptor binding

Ying Wei1, Ralf-Peter Czekay2, Liliane Robillard1, Matthias C. Kugler1, Feng Zhang1, Kevin K. Kim1, Jian-ping Xiong3, Martin J. Humphries4, and Harold A. Chapman1

1 Department of Medicine and Pulmonary and Critical Care Division, University of California, San Francisco, San Francisco, CA 94143
2 Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037
3 Structural Biology Program, Massachusetts General Hospital, Charlestown, MA 02129
4 Wellcome Trust Centre for Cell-Matrix Research, School of Biological Sciences, University of Manchester, Manchester M13 9PT, England, UK

Correspondence to Harold A. Chapman: halchap{at}itsa.ucsf.edu; or Ying Wei: yingwei{at}itsa.ucsf.edu

Urokinase-type plasminogen activator receptors (uPARs), up-regulated during tumor progression, associate with ß1 integrins, localizing urokinase to sites of cell attachment. Binding of uPAR to the ß-propeller of {alpha}3ß1 empowers vitronectin adhesion by this integrin. How uPAR modifies other ß1 integrins remains unknown. Using recombinant proteins, we found uPAR directly binds {alpha}5ß1 and rather than blocking, renders fibronectin (Fn) binding by {alpha}5ß1 Arg-Gly-Asp (RGD) resistant. This resulted from RGD-independent binding of {alpha}5ß1–uPAR to Fn type III repeats 12–15 in addition to type III repeats 9–11 bound by {alpha}5ß1. Suppression of endogenous uPAR by small interfering RNA in tumor cells promoted weaker, RGD-sensitive Fn adhesion and altered overall {alpha}5ß1 conformation. A ß1 peptide (res 224NLDSPEGGF232) that models near the known {alpha}-chain uPAR-binding region, or a ß1-chain Ser227Ala point mutation, abrogated effects of uPAR on {alpha}5ß1. Direct binding and regulation of {alpha}5ß1 by uPAR implies a modified "bent" integrin conformation can function in an alternative activation state with this and possibly other cis-acting membrane ligands.

Abbreviations used in this paper: ERK, extracellular signal–regulated kinase; Fn, fibronectin; LIBS, ligand-induced binding site; Ln-5, laminin-5; PAI-1, plasminogen activator inhibitor-1; RGD, Arg-Gly-Asp; siRNA, small interfering RNA; suPAR, soluble uPAR; Tet, tetracycline; uPA, urokinase-type plasminogen activator; uPAR, uPA receptor; Vn, vitronectin.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents